Wilson M, Wasserman M, Breton MC, McDade C, Earnshaw S, Farkouh R. Potential clinical and economic impact of switching from the 13-valent to 10-valent pneumococcal conjugate vaccine in Canada. Poster presented at the 2016 Canadian Immunization Conference; December 6, 2016. Ottawa, Canada.
Li R, Stewart B, McNeil MM, Duffy J, Nelson J, Kawai AT, Baxter R, Belongia EA, Weintraub E. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons. Pharmacoepidemiol Drug Saf. 2016 Aug;25(8):928-34. doi: 10.1002/pds.3996
Standaert B, Mauskopf JA, Severens JL. Economic evaluation of vaccines designed to prevent infectious disease: good practices task force. Presented at the 2016 ISPOR 21st Annual International Meeting; May 23, 2016. Washington, DC.
Yih WK, Kulldorff M, Sandhu SK, Zichittella L, Maro JC, Cole DV, Jin R, Kawai AT, Baker MA, Liu C, McMahill-Walraven CN, Selvan MS, Platt R, Nguyen MD, Lee GM. Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System. Pharmacoepidemiol Drug Saf. 2016 May;25(5):481-92. doi: 10.1002/pds.3908
Poulos C. A review of discrete choice experiment studies of preferences for vaccine features. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 24, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A220.
Buck PO, Gordon LD, Meyers J, Parikh R, Kurosky S, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease: a US database study. Poster presented at the National Foundation for Infectious Diseases 19th Annual Conference on Vaccine Research; April 2016. Bethesda, MD.
Liu Z, Eaton SC, McQuay LJ, Mines D, Irish WD, Wang L. Protective value of influenza vaccination for other household members of vaccinated children. Poster presented at the 2003 41st Annual Meeting of the Infectious Disease Society of America; October 2003. San Diego, CA.
Poulos C, Cahn D, Whittington D, Thoa L, Utomo N, Hoa N. Household demand for typhoid fever vaccines in Hue City, Vietnam: implications for immunization programs. Poster presented at the 4th World Congress of the International Health Economics Association; June 2003.